Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Thyroid Neoplasms 1Sarcoma, Ewing 1Pain 1Osteosarcoma 1Osteonecrosis 1Nasopharyngeal Carcinoma 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphedema 1Leukemia 1Hodgkin Disease 1Exostoses, Multiple Hereditary 1Deglutition Disorders 1Colonic Neoplasms 1Chondrosarcoma 1Breast Neoplasms 1Bone Neoplasms 1Anemia, Sickle Cell 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Capecitabine 222Letrozole 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 133Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Range of Motion, Articular × Clear all
NCT06144164 2025-11-10

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 3 Recruiting
285 enrolled
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡